Report Detail

Pharma & Healthcare Global Parasitic Diseases Therapeutic Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM3811465
  • |
  • 02 August, 2024
  • |
  • Global
  • |
  • 93 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Parasitic Diseases Therapeutic market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Parasitic diseases include amebiasis, trichomoniasis, trypanosomiasis, giardiasis, African sleeping sickness, leishmaniasis, and malaria.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Parasitic Diseases Therapeutic industry chain, the market status of Commercial (Peptides Medicine, Insect Repellent), Household (Peptides Medicine, Insect Repellent), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Parasitic Diseases Therapeutic.
Regionally, the report analyzes the Parasitic Diseases Therapeutic markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Parasitic Diseases Therapeutic market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Parasitic Diseases Therapeutic market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Parasitic Diseases Therapeutic industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Peptides Medicine, Insect Repellent).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Parasitic Diseases Therapeutic market.
Regional Analysis: The report involves examining the Parasitic Diseases Therapeutic market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Parasitic Diseases Therapeutic market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Parasitic Diseases Therapeutic:
Company Analysis: Report covers individual Parasitic Diseases Therapeutic players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Parasitic Diseases Therapeutic This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Commercial, Household).
Technology Analysis: Report covers specific technologies relevant to Parasitic Diseases Therapeutic. It assesses the current state, advancements, and potential future developments in Parasitic Diseases Therapeutic areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Parasitic Diseases Therapeutic market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Parasitic Diseases Therapeutic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Peptides Medicine
Insect Repellent
Acaricide
Other
Market segment by Application
Commercial
Household
Market segment by players, this report covers
Bayer
F. Hoffmann-La Roche
GlaxoSmithKline
Pfizer
Sanaria
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Parasitic Diseases Therapeutic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Parasitic Diseases Therapeutic, with revenue, gross margin and global market share of Parasitic Diseases Therapeutic from 2019 to 2024.
Chapter 3, the Parasitic Diseases Therapeutic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Parasitic Diseases Therapeutic market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Parasitic Diseases Therapeutic.
Chapter 13, to describe Parasitic Diseases Therapeutic research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Parasitic Diseases Therapeutic
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Parasitic Diseases Therapeutic by Type
    • 1.3.1 Overview: Global Parasitic Diseases Therapeutic Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Parasitic Diseases Therapeutic Consumption Value Market Share by Type in 2023
    • 1.3.3 Peptides Medicine
    • 1.3.4 Insect Repellent
    • 1.3.5 Acaricide
    • 1.3.6 Other
  • 1.4 Global Parasitic Diseases Therapeutic Market by Application
    • 1.4.1 Overview: Global Parasitic Diseases Therapeutic Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Commercial
    • 1.4.3 Household
  • 1.5 Global Parasitic Diseases Therapeutic Market Size & Forecast
  • 1.6 Global Parasitic Diseases Therapeutic Market Size and Forecast by Region
    • 1.6.1 Global Parasitic Diseases Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Parasitic Diseases Therapeutic Market Size by Region, (2019-2030)
    • 1.6.3 North America Parasitic Diseases Therapeutic Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Parasitic Diseases Therapeutic Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Parasitic Diseases Therapeutic Market Size and Prospect (2019-2030)
    • 1.6.6 South America Parasitic Diseases Therapeutic Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Parasitic Diseases Therapeutic Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Bayer
    • 2.1.1 Bayer Details
    • 2.1.2 Bayer Major Business
    • 2.1.3 Bayer Parasitic Diseases Therapeutic Product and Solutions
    • 2.1.4 Bayer Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Bayer Recent Developments and Future Plans
  • 2.2 F. Hoffmann-La Roche
    • 2.2.1 F. Hoffmann-La Roche Details
    • 2.2.2 F. Hoffmann-La Roche Major Business
    • 2.2.3 F. Hoffmann-La Roche Parasitic Diseases Therapeutic Product and Solutions
    • 2.2.4 F. Hoffmann-La Roche Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 F. Hoffmann-La Roche Recent Developments and Future Plans
  • 2.3 GlaxoSmithKline
    • 2.3.1 GlaxoSmithKline Details
    • 2.3.2 GlaxoSmithKline Major Business
    • 2.3.3 GlaxoSmithKline Parasitic Diseases Therapeutic Product and Solutions
    • 2.3.4 GlaxoSmithKline Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.4 Pfizer
    • 2.4.1 Pfizer Details
    • 2.4.2 Pfizer Major Business
    • 2.4.3 Pfizer Parasitic Diseases Therapeutic Product and Solutions
    • 2.4.4 Pfizer Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Pfizer Recent Developments and Future Plans
  • 2.5 Sanaria
    • 2.5.1 Sanaria Details
    • 2.5.2 Sanaria Major Business
    • 2.5.3 Sanaria Parasitic Diseases Therapeutic Product and Solutions
    • 2.5.4 Sanaria Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Sanaria Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Parasitic Diseases Therapeutic Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Parasitic Diseases Therapeutic by Company Revenue
    • 3.2.2 Top 3 Parasitic Diseases Therapeutic Players Market Share in 2023
    • 3.2.3 Top 6 Parasitic Diseases Therapeutic Players Market Share in 2023
  • 3.3 Parasitic Diseases Therapeutic Market: Overall Company Footprint Analysis
    • 3.3.1 Parasitic Diseases Therapeutic Market: Region Footprint
    • 3.3.2 Parasitic Diseases Therapeutic Market: Company Product Type Footprint
    • 3.3.3 Parasitic Diseases Therapeutic Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Parasitic Diseases Therapeutic Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Parasitic Diseases Therapeutic Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Parasitic Diseases Therapeutic Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Parasitic Diseases Therapeutic Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Parasitic Diseases Therapeutic Consumption Value by Type (2019-2030)
  • 6.2 North America Parasitic Diseases Therapeutic Consumption Value by Application (2019-2030)
  • 6.3 North America Parasitic Diseases Therapeutic Market Size by Country
    • 6.3.1 North America Parasitic Diseases Therapeutic Consumption Value by Country (2019-2030)
    • 6.3.2 United States Parasitic Diseases Therapeutic Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Parasitic Diseases Therapeutic Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Parasitic Diseases Therapeutic Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Parasitic Diseases Therapeutic Consumption Value by Type (2019-2030)
  • 7.2 Europe Parasitic Diseases Therapeutic Consumption Value by Application (2019-2030)
  • 7.3 Europe Parasitic Diseases Therapeutic Market Size by Country
    • 7.3.1 Europe Parasitic Diseases Therapeutic Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Parasitic Diseases Therapeutic Market Size and Forecast (2019-2030)
    • 7.3.3 France Parasitic Diseases Therapeutic Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Parasitic Diseases Therapeutic Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Parasitic Diseases Therapeutic Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Parasitic Diseases Therapeutic Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Parasitic Diseases Therapeutic Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Parasitic Diseases Therapeutic Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Parasitic Diseases Therapeutic Market Size by Region
    • 8.3.1 Asia-Pacific Parasitic Diseases Therapeutic Consumption Value by Region (2019-2030)
    • 8.3.2 China Parasitic Diseases Therapeutic Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Parasitic Diseases Therapeutic Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Parasitic Diseases Therapeutic Market Size and Forecast (2019-2030)
    • 8.3.5 India Parasitic Diseases Therapeutic Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Parasitic Diseases Therapeutic Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Parasitic Diseases Therapeutic Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Parasitic Diseases Therapeutic Consumption Value by Type (2019-2030)
  • 9.2 South America Parasitic Diseases Therapeutic Consumption Value by Application (2019-2030)
  • 9.3 South America Parasitic Diseases Therapeutic Market Size by Country
    • 9.3.1 South America Parasitic Diseases Therapeutic Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Parasitic Diseases Therapeutic Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Parasitic Diseases Therapeutic Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Parasitic Diseases Therapeutic Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Parasitic Diseases Therapeutic Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Country
    • 10.3.1 Middle East & Africa Parasitic Diseases Therapeutic Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Parasitic Diseases Therapeutic Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Parasitic Diseases Therapeutic Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Parasitic Diseases Therapeutic Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Parasitic Diseases Therapeutic Market Drivers
  • 11.2 Parasitic Diseases Therapeutic Market Restraints
  • 11.3 Parasitic Diseases Therapeutic Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Parasitic Diseases Therapeutic Industry Chain
  • 12.2 Parasitic Diseases Therapeutic Upstream Analysis
  • 12.3 Parasitic Diseases Therapeutic Midstream Analysis
  • 12.4 Parasitic Diseases Therapeutic Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Parasitic Diseases Therapeutic. Industry analysis & Market Report on Parasitic Diseases Therapeutic is a syndicated market report, published as Global Parasitic Diseases Therapeutic Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Parasitic Diseases Therapeutic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report